C. Sarrazin
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 59
- Hepatitis C virus research 58
- Liver Diseases and Immunity 6
- Epidemiology 38
- Hepatitis B Virus Studies 24
- Liver Disease Diagnosis and Treatment 17
- Co-authors
- Stefan ZeuzemThomas BergHolger HinrichsenHeiner WedemeyerS MaussMichael P. MannsD. HueppeBernd Moeller
- Journals
- Journal of Hepatology (59 papers)Digestive and Liver Disease (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Tetrahedron (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
C. Sarrazin
79 papers receiving 603 citations
Peers
Comparison fields: 5 of 59
- Hepatology 518
- Epidemiology 522
- Infectious Diseases 151
- Rheumatology 42
- Virology 10
Countries citing papers authored by C. Sarrazin
This map shows the geographic impact of C. Sarrazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sarrazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sarrazin more than expected).
Fields of papers citing papers by C. Sarrazin
This network shows the impact of papers produced by C. Sarrazin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sarrazin. The network helps show where C. Sarrazin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Sarrazin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 1 | |
| 2 | 2013 | 3 | |
| 3 | 2013 | 2 | |
| 4 | 2012 | 4 | |
| 5 | 2011 | 1 | |
| 6 | 2011 | 9 | |
| 7 | 2011 | 1 | |
| 8 | 2009 | 51 | |
| 9 | 2008 | 18 | |
| 10 | 2008 | 164 | |
| 11 | 2007 | 1 | |
| 12 | 2006 | 25 | |
| 13 | 2003 | 1 | |
| 14 | 2003 | 1 | |
| 15 | 2000 | 10 | |
| 16 | 1994 | 13 | |
| 17 | 1983 | 5 | |
| 18 | Epidemiological studies of maedi-visna. Confirmation of outbreaks. | 1980 | 1 |
| 19 | Isolation of a strain of visna-maedi virus from sheep in France. | 1980 | 2 |
| 20 | 1980 | 5 |
About C. Sarrazin
C. Sarrazin is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Immunology, having authored 83 papers that have together received 637 indexed citations. Recurring topics across this work include Hepatitis C virus research (58 papers), Hepatitis B Virus Studies (24 papers), Liver Disease Diagnosis and Treatment (17 papers), HIV/AIDS drug development and treatment (12 papers), Systemic Lupus Erythematosus Research (10 papers), Immunodeficiency and Autoimmune Disorders (10 papers), Liver Diseases and Immunity (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Hepatology (518 citations), Epidemiology (522 citations), Infectious Diseases (151 citations), Rheumatology (42 citations) and Virology (10 citations). C. Sarrazin has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Stefan Zeuzem, Thomas Berg, Holger Hinrichsen, Heiner Wedemeyer, S Mauss, Michael P. Manns, D. Hueppe, Bernd Moeller, E Zehnter and Eva Herrmann. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Alimentary Pharmacology & Therapeutics, Tetrahedron and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.